Antinociceptive effect of peripheral serotonin 5-HT2B receptor activation on neuropathic pain

[1]  G. Ahern.  5-HT and the immune system. , 2011, Current opinion in pharmacology.

[2]  Wei-Hsin Sun,et al.  Serotonin Receptor 5-HT2B Mediates Serotonin-Induced Mechanical Hyperalgesia , 2011, The Journal of Neuroscience.

[3]  Gila Moalem-Taylor,et al.  The neuro-immune balance in neuropathic pain: Involvement of inflammatory immune cells, immune-like glial cells and cytokines , 2010, Journal of Neuroimmunology.

[4]  A. Nakae,et al.  5‐HT2C receptor agonists attenuate pain‐related behaviour in a rat model of trigeminal neuropathic pain , 2010, European journal of pain.

[5]  G. Dussor,et al.  Central modulation of pain. , 2010, The Journal of clinical investigation.

[6]  R. Dubner,et al.  Interactions between the immune and nervous systems in pain , 2010, Nature Medicine.

[7]  T. Nurmikko,et al.  EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision , 2010, European journal of neurology.

[8]  T. Jensen,et al.  The evidence for pharmacological treatment of neuropathic pain , 2010, PAIN.

[9]  A. Eschalier,et al.  Disrupting 5-HT2A Receptor/PDZ Protein Interactions Reduces Hyperalgesia and Enhances SSRI Efficacy in Neuropathic Pain. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  M. Zimmermann,et al.  Subtype-specific changes in 5-HT receptor-mediated modulation of C fibre-evoked spinal field potentials are triggered by peripheral nerve injury , 2010, Neuroscience.

[11]  J. Furness,et al.  A selective, high affinity 5‐HT2B receptor antagonist inhibits visceral hypersensitivity in rats , 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[12]  T. Dinan,et al.  5‐HT2B receptors modulate visceral hypersensitivity in a stress‐sensitive animal model of brain‐gut axis dysfunction , 2009, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[13]  D. Hervé,et al.  Role of Serotonin via 5-HT2B Receptors in the Reinforcing Effects of MDMA in Mice , 2009, PloS one.

[14]  Maria Fitzgerald,et al.  T-Cell Infiltration and Signaling in the Adult Dorsal Spinal Cord Is a Major Contributor to Neuropathic Pain-Like Hypersensitivity , 2009, The Journal of Neuroscience.

[15]  Stephen B. McMahon,et al.  Current Challenges in Glia-Pain Biology , 2009, Neuron.

[16]  F. Di Virgilio,et al.  5-Hydroxytryptamine Modulates Migration, Cytokine and Chemokine Release and T-Cell Priming Capacity of Dendritic Cells In Vitro and In Vivo , 2009, PLoS ONE.

[17]  S. Gordon,et al.  Alternative activation of macrophages: an immunologic functional perspective. , 2009, Annual review of immunology.

[18]  A. Guzel,et al.  Macrophage depletion delays progression of neuropathic pain in diabetic animals , 2009, Naunyn-Schmiedeberg's Archives of Pharmacology.

[19]  M. Hamon,et al.  Serotonin 5-HT2A receptor involvement and Fos expression at the spinal level in vincristine-induced neuropathy in the rat , 2008, PAIN.

[20]  D. Cussac,et al.  Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells. , 2008, European journal of pharmacology.

[21]  J. Fermanian,et al.  Neuropathic pain: Are there distinct subtypes depending on the aetiology or anatomical lesion? , 2008, PAIN.

[22]  M. Hamon,et al.  Differential Implication of Proinflammatory Cytokine Interleukin-6 in the Development of Cephalic versus Extracephalic Neuropathic Pain in Rats , 2008, The Journal of Neuroscience.

[23]  M. Levite.  Neurotransmitters activate T-cells and elicit crucial functions via neurotransmitter receptors. , 2008, Current opinion in pharmacology.

[24]  M. Hamon,et al.  Role of spinal serotonin 5-HT2A receptor in 2′,3′-dideoxycytidine-induced neuropathic pain in the rat and the mouse , 2008, PAIN®.

[25]  V. Setola,et al.  Serotonin 5-HT2B Receptors Are Required for 3,4-Methylenedioxymethamphetamine-Induced Hyperlocomotion and 5-HT Release In Vivo and In Vitro , 2008, The Journal of Neuroscience.

[26]  A. Nakae,et al.  Serotonin2C receptor mRNA editing in neuropathic pain model , 2008, Neuroscience Research.

[27]  Tim Hucho,et al.  Signaling Pathways in Sensitization: Toward a Nociceptor Cell Biology , 2007, Neuron.

[28]  S. Bevan,et al.  Role of the cysteine protease cathepsin S in neuropathic hyperalgesia , 2007, PAIN.

[29]  D. Julius,et al.  Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice , 2007, PAIN.

[30]  S. Pingle,et al.  A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. , 2006, Blood.

[31]  F. Di Virgilio,et al.  5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes. , 2005, International immunology.

[32]  Ya-Yun Wang,et al.  Changes of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by bee venom-induced inflammatory pain , 2005, Neuroscience Letters.

[33]  G. Moalem,et al.  T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats , 2004, Neuroscience.

[34]  H. Lee,et al.  Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model , 2004, Neuroreport.

[35]  C. Sommer,et al.  Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia , 2004, Neuroscience Letters.

[36]  G. Bennett,et al.  Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy , 2004, Pain.

[37]  H. Obata,et al.  Antiallodynic effects of intrathecally administered 5-HT2C receptor agonists in rats with nerve injury , 2004, Pain.

[38]  E. McLachlan,et al.  Distinct functional types of macrophage in dorsal root ganglia and spinal nerves proximal to sciatic and spinal nerve transections in the rat , 2003, Experimental Neurology.

[39]  G. Stoll,et al.  Caught in the Act: In Vivo Mapping of Macrophage Infiltration in Nerve Injury by Magnetic Resonance Imaging , 2003, The Journal of Neuroscience.

[40]  D. Tracey,et al.  Inflammation and hyperalgesia induced by nerve injury in the rat: a key role of mast cells , 2003, Pain.

[41]  L. Maroteaux,et al.  Agonist actions of dihydroergotamine at 5‐HT2B and 5‐HT2C receptors and their possible relevance to antimigraine efficacy , 2003, British journal of pharmacology.

[42]  D. Nelson,et al.  Neurogenic Dural Protein Extravasation Induced by Meta-Chlorophenylpiperazine (Mcpp) Involves Nitric Oxide and 5-HT2B Receptor Activation , 2003, Cephalalgia : an international journal of headache.

[43]  D. Spanswick,et al.  Serotonin receptor mRNA expression in rat dorsal root ganglion neurons , 2003, Neuroscience Letters.

[44]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[45]  D. Harmer,et al.  5‐HT2B receptors play a key role in mediating the excitatory effects of 5‐HT in human colon in vitro , 2002, British journal of pharmacology.

[46]  Ya-Yun Wang,et al.  Changes of the expression of 5-HT receptor subtype mRNAs in rat dorsal root ganglion by complete Freund's adjuvant-induced inflammation , 2001, Neuroscience Letters.

[47]  K. Schauenstein,et al.  mRNA Expression of Serotonin Receptors in Cells of the Immune Tissues of the Rat , 2000, Brain, Behavior, and Immunity.

[48]  D. Tracey,et al.  Depletion of macrophages reduces axonal degeneration and hyperalgesia following nerve injury , 2000, Pain.

[49]  Atsushi Tokunaga,et al.  Activating Transcription Factor 3 (ATF3) Induction by Axotomy in Sensory and Motoneurons: A Novel Neuronal Marker of Nerve Injury , 2000, Molecular and Cellular Neuroscience.

[50]  S. Bowersox,et al.  Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy. , 1999, The Journal of pharmacology and experimental therapeutics.

[51]  T. Jensen,et al.  Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action , 1999, PAIN®.

[52]  R. Porter,et al.  Functional characterization of agonists at recombinant human 5‐HT2A, 5‐HT2B and 5‐HT2C receptors in CHO‐K1 cells , 1999, British journal of pharmacology.

[53]  H. Mitoma,et al.  Differential response of macrophage subpopulations to myelin degradation in the injured rat sciatic nerve , 1999, Journal of neurocytology.

[54]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[55]  R M Eglen,et al.  RS‐127445: a selective, high affinity, orally bioavailable 5‐HT2B receptor antagonist , 1999, British journal of pharmacology.

[56]  C. Woolf,et al.  Neuropathic pain: aetiology, symptoms, mechanisms, and management , 1999, The Lancet.

[57]  T. Blackburn,et al.  Evidence for expression of the 5-hydroxytryptamine-2B receptor protein in the rat central nervous system , 1997, Neuroscience.

[58]  A. Probst,et al.  Activation of Meningeal 5‐HT2B Receptors: An Early Step in the Generation of Migraine Headache? , 1996, The European journal of neuroscience.

[59]  J. Levine,et al.  5-hydroxytryptamine receptor subtype messenger RNAs in rat peripheral sensory and sympathetic ganglia: A polymerase chain reaction study , 1996, Neuroscience.

[60]  J. Stamford.  Descending control of pain. , 1995, British journal of anaesthesia.

[61]  J. Grondin,et al.  Induction of interleukin-6 in axotomized sensory neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[62]  K. Thor,et al.  5-hydroxytryptamine2A, 5-hydroxytryptamine2B, and 5-hydroxytryptamine2C receptor mRNA expression in the spinal cord of rat, cat, monkey and human. , 1994, Neuroreport.

[63]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[64]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[65]  J. Launay,et al.  Deconstructing Antiobesity Compound Action: Requirement of Serotonin 5-HT2B Receptors for Dexfenfluramine Anorectic Effects , 2011, Neuropsychopharmacology.

[66]  J. Mallet,et al.  Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Serotonin Activates Dendritic Cell Function in the Context of Gut Inflammation , 2011 .

[67]  C. Sommer.  Serotonin in Pain and Pain Control , 2010 .

[68]  M. Idzko,et al.  Serotoninergic receptors on human airway epithelial cells. , 2007, American journal of respiratory cell and molecular biology.

[69]  B. Largent,et al.  Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine. , 2000, Molecular pharmacology.

[70]  W. Dixon,et al.  Efficient analysis of experimental observations. , 1980, Annual review of pharmacology and toxicology.